Huston J P, Hasenöhrl R U
Institute of Physiological Psychology I, Heinrich-Heine-University of Düsseldorf, Germany.
Behav Brain Res. 1995 Jan 23;66(1-2):117-27. doi: 10.1016/0166-4328(94)00132-y.
The neurokinin substance P (SP) can have neurotrophic as well as memory-promoting effects. The study of its mechanisms may provide new insights into processes underlying learning and neurodegenerative disorders. Our work shows that SP, when applied peripherally (i.p.), promotes memory and is reinforcing at the same dose of 37 nmol/kg. Most important, however, is the finding that these effects seemed to be encoded by different SP-sequences, since the N-terminal SP1-7 (185 nmol/kg) enhanced memory, whereas C-terminal hepta- and hexapeptide sequences of SP proved to be reinforcing in a dose equimolar to SP. These differential behavioral effects were paralleled by selective and site-specific changes in dopamine (DA) activity, as both SP and its C-, but not N-terminus, increased extracellular DA in the nucleus accumbens (NAc), but not in the neostriatum. The neurochemical changes lasted at least 2 h after injection. Direct application of SP (0.74 pmol) into the region of the nucleus basalis magnocellularis (NBM) was also memory-promoting and reinforcing, and again, these effects were differentially produced by the N-terminus and C-terminus, supporting the proposed structure-activity relationship for SP's effects on memory and reinforcement. In addition, it was found that a single injection of SP into the NBM led to an increase of extracellular DA in the contralateral NAc. This effect of SP was observed only in those animals where SP was reinforcing, providing evidence for a lateralized relationship between reinforcement induced by injection of SP into the NBM and DA activity in the NAc. Furthermore, the outcome of a series of experiments suggests, that SP may not only be considered to have memory-promoting effects in normal animals, but can also improve functional recovery after unilateral 6-OHDA lesion of the substantia nigra and after lesions of the hippocampus, and can counteract age-related performance deficits.
神经激肽P物质(SP)具有神经营养以及促进记忆的作用。对其作用机制的研究可能为学习和神经退行性疾病的潜在过程提供新的见解。我们的研究表明,外周注射(腹腔注射)37 nmol/kg剂量的SP可促进记忆并具有强化作用。然而,最重要的是发现这些作用似乎由不同的SP序列编码,因为N端的SP1-7(185 nmol/kg)增强记忆,而SP的C端七肽和六肽序列在与SP等摩尔剂量时具有强化作用。这些不同的行为效应与多巴胺(DA)活性的选择性和位点特异性变化平行,因为SP及其C端(而非N端)可增加伏隔核(NAc)而非新纹状体的细胞外DA。注射后神经化学变化至少持续2小时。向基底大细胞核(NBM)区域直接注射SP(0.74 pmol)也具有促进记忆和强化作用,同样,这些作用由N端和C端差异产生,支持了所提出的SP对记忆和强化作用的结构-活性关系。此外,发现向NBM单次注射SP会导致对侧NAc的细胞外DA增加。仅在那些SP具有强化作用的动物中观察到SP的这种效应,为向NBM注射SP诱导的强化与NAc中DA活性之间的侧化关系提供了证据。此外,一系列实验结果表明,SP不仅在正常动物中可被认为具有促进记忆的作用,还可改善黑质单侧6-OHDA损伤以及海马损伤后的功能恢复,并可抵消与年龄相关的行为缺陷。